11 results
8-K
EX-10.1
RPHM
Reneo Pharmaceuticals Inc
5 May 23
Reneo Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:33pm
for the Engagement Letters, there is no broker, finder or other party that is entitled to receive from the Company any brokerage or finder’s fee or other fee … in Section 6.1.
7.11 “Engagement Letters” mean each of the engagement letters by and between the Company and the Placement Agents, each dated on or about
DEF 14A
RPHM
Reneo Pharmaceuticals Inc
22 Apr 22
Definitive proxy
4:05pm
oversee corporate accounting and financial reporting processes;
Managing the selection, engagement, qualifications, independence, and performance … and Nasdaq described above, the Compensation Committee engaged Radford/Aon (“Radford”) as a compensation consultant. As part of its engagement, Radford
10-K
2021 FY
EX-10.12
RPHM
Reneo Pharmaceuticals Inc
23 Mar 22
Annual report
4:38pm
person designated by the Company, perform business development research and engagement with potential partners and licensees/licensors, intellectual … , claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto.
(f)“Proceeding” includes any threatened
8-K
EX-3.2
RPHM
Reneo Pharmaceuticals Inc
13 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:36pm
contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.
Section 35. Voting of Securities Owned
424B4
081b8r3
9 Apr 21
Prospectus supplement with pricing info
4:41pm
S-1/A
xf7zac16r38f00xd
5 Apr 21
IPO registration (amended)
9:12am
S-1
wd34ekflefetj3i3j0t
19 Mar 21
IPO registration
5:27pm
S-1
EX-3.3
jfjbgd52yordv
19 Mar 21
IPO registration
5:27pm
S-1
EX-3.4
3pgo f2gqc1
19 Mar 21
IPO registration
5:27pm
S-1
EX-10.8
j6o4 963tppqr6
19 Mar 21
IPO registration
5:27pm
- Prev
- 1
- Next